These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18780680)

  • 1. Specialists play down risk of jaw condition.
    Stassen LF
    J Ir Dent Assoc; 2008; 54(4):153. PubMed ID: 18780680
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of bisphosphonate-induced osteonecrosis of the jaw.
    Schilling J
    Northwest Dent; 2008; 87(3):34-5, 37-8, 40. PubMed ID: 18663869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating osteonecrosis.
    Harrison Z
    Br Dent J; 2006 Mar; 200(5):242-3. PubMed ID: 16528300
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
    Landis BN; Dojcinovic I; Richter M; Hugentobler M
    J Intern Med; 2007 Jan; 261(1):101-2. PubMed ID: 17222173
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonates and their impact on patient treatment.
    Kurtzman GM; Silverstein LH; Peden J
    Pract Proced Aesthet Dent; 2006 Jun; 18(5):297-8. PubMed ID: 16903540
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
    Bagán J; Blade J; Cozar JM; Constela M; García Sanz R; Gómez Veiga F; Lahuerta JJ; Lluch A; Massuti B; Morote J; San Miguel JF; Solsona E
    Med Oral Patol Oral Cir Bucal; 2007 Aug; 12(4):E336-40. PubMed ID: 17664922
    [No Abstract]   [Full Text] [Related]  

  • 8. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Campisi G; Fedele S; Colella G; Lo Casto A; Fusco V
    J Rheumatol; 2009 Feb; 36(2):451-3; author reply 453. PubMed ID: 19208579
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.
    Marx RE
    Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for treating patients taking bisphosphonates prior to dental extractions.
    Rogers S; Rahman N; Ryan D; Flint S; Healy C; Stassen LF
    J Ir Dent Assoc; 2010; 56(1):40. PubMed ID: 20337145
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
    J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug induced osteonecrosis of the jaws.
    Weeda LW
    J Tenn Dent Assoc; 2006; 86(2):18-9. PubMed ID: 16895006
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonates: a potential threat to your patients.
    Dreiman BB
    J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
    [No Abstract]   [Full Text] [Related]  

  • 18. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    Aust Endod J; 2009 Dec; 35(3):119-30. PubMed ID: 19961450
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
    Kyrgidis A; Koloutsos G; Vahtsevanos K
    Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonates and osteonecrosis of the jaws.
    Mariotti A
    J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.